PLEXUS CORP quarterly report, Q3 FY2017

Plexus Corp. — Form 10-Q summary

Reporting period: Third quarter and first nine months of fiscal 2017, ended July 1, 2017. The quarter comprised 13 weeks. Amounts below are in U.S. dollars; financial-statement amounts are in millions unless noted.

Business context and performance

Plexus provides electronics manufacturing services, including product design, manufacturing, fulfillment and sustaining services, primarily for mid-to-low-volume, higher-complexity programs. It reports in the Americas (AMER), Asia-Pacific (APAC) and Europe, Middle East and Africa (EMEA).

MetricQ3 FY2017Q3 FY2016Nine months FY2017Nine months FY2016
Net sales$618.8$667.6$1,858.2$1,902.9
Gross profit$61.2$62.5$189.3$165.8
Gross margin9.9%9.4%10.2%8.7%
Operating income$29.5$30.9$95.9$75.8
Operating margin4.8%4.6%5.2%4.0%
Net income$25.6$26.1$83.1$57.3
Diluted EPS$0.74$0.76$2.40$1.68

Key financial changes

  • Quarter: Sales declined 7.3% year over year, while gross and operating margins improved. Net income fell $0.5 million and diluted EPS declined $0.02.
  • Nine months: Sales declined 2.3%, but gross profit increased 14.2% and operating income increased 26.6%. Net income rose $25.7 million and diluted EPS increased $0.72. Higher gross margins, lower restructuring charges and improved other income contributed to the improvement.
  • Regional mix: Q3 AMER sales fell 26.2% and segment operating income declined to $7.4 million from $22.1 million. APAC sales grew 11.4% and operating income rose to $49.8 million from $38.3 million. EMEA sales grew 29.5%, but the segment recorded a $0.8 million operating loss. For the nine months, AMER remained weaker while APAC led profit growth.
  • Market sectors: Q3 Communications sales fell to $98.7 million from $155.6 million; Healthcare/Life Sciences and Defense/Security/Aerospace grew modestly. Over nine months, Industrial/Commercial and Healthcare/Life Sciences grew, while Communications declined materially.
  • Taxes: Effective tax rates were 6.5% for Q3 and 8.5% for the first nine months, versus 9.1% and 12.6% a year earlier. Management cited earnings in lower-tax jurisdictions and a $1.5 million APAC tax benefit.

Cash flow, balance sheet and liquidity

  • Nine-month operating cash flow was $121.9 million, versus $122.6 million a year earlier. Capital expenditures were $24.4 million, producing reported free cash flow of $97.5 million versus $98.8 million.
  • Cash, cash equivalents and restricted cash totaled $520.0 million, up from $433.0 million at fiscal year-end. Approximately 98.2% of cash was held outside the United States; management said it intended to permanently reinvest foreign-held funds and did not anticipate another similar repatriation absent tax reform.
  • Total debt, capital lease and other financing obligations were $293.4 million, including $88.0 million drawn on the revolving facility and $175.0 million of 5.20% senior notes due June 15, 2018. The notes were classified as current because maturity was within 12 months. The company reported compliance with debt covenants.
  • The $300 million revolving credit facility expires in July 2021; its Q3 weighted-average rate was 2.221%. Management expected to refinance the notes with a similar long-term product, but gave no assurance of availability or favorable terms. It also said cash, operating cash flow and available credit should meet needs for the next 12 months.
  • Inventory was $653.1 million, up from $564.1 million at October 1, 2016. Inventory days increased to 107 from 87 a year earlier; management attributed the build to new-program ramps and longer component lead times. It anticipated a meaningful Q4 reduction and more normalized levels in fiscal 2018, with no assurance.
  • Receivable-sale programs generated $283.1 million of proceeds during the nine months on $284.6 million of receivables sold. The programs are non-committed and proceeds affect operating cash flow; increased factoring materially supported receivables cash flows.

Outlook, risks and unusual items

  • Management estimated a fiscal 2017 effective tax rate of 8.0%–9.0% and funded capital expenditures of approximately $45–$50 million for the year. It stated targets of 4.7%–5.0% operating margin, 12% organic revenue growth and 5% economic return; these are management goals, not a specific quarterly revenue forecast.
  • Management attributed margin gains to supply-chain productivity, favorable customer mix, and lower warranty and inventory-obsolescence expenses. It cited lower AMER demand and Communications-sector weakness as offsets, alongside APAC program ramps.
  • Key stated risks include customer forecast changes, delays or cancellations; customer and program concentration; start-up and transition execution; component shortages and longer lead times; excess or obsolete inventory; pricing and margin pressure; foreign exchange, political and trade changes; and the pending U.K. exit from the EU.
  • No restructuring charges were recorded in the first nine months of FY2017, compared with $5.2 million in the prior-year period. A $15.7 million facility-related lease capitalization was a non-cash financing transaction. The company’s litigation was described as ordinary-course and not expected to have a material effect.
  • The company said the new revenue-recognition standard, effective for it in FY2019, will shift significant revenue from recognition at delivery to recognition over time and could materially affect reported results and balance-sheet presentation. The transition method had not been selected.

Important facts for investors to verify

  • Whether the Q4 inventory reduction and subsequent normalization occur as management anticipated, given elevated inventory days and longer component lead times.
  • How the AMER downturn and Communications-sector weakness compare with continuing APAC growth, and whether new program ramps deliver expected revenue and profitability.
  • Refinancing progress and terms for the $175 million notes due June 2018, while tracking revolver usage and covenant compliance.
  • The sustainability of cash generation and the extent to which operating cash flow depends on receivable factoring and working-capital movements.
  • Actual fiscal 2017 tax rate and capital expenditures versus management estimates, and the eventual financial-statement effects and transition method for the FY2019 revenue standard.